Outset Medical, Inc. (OM) Revenue History
Annual and quarterly revenue from 2018 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
OM Revenue Growth
Revenue Breakdown (FY 2025)
OM's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
OM Revenue Analysis (2018–2025)
As of May 8, 2026, Outset Medical, Inc. (OM) generated trailing twelve-month (TTM) revenue of $117.6 million, reflecting moderate decline in growth of -6.3% year-over-year. The most recent quarter (Q1 2026) recorded $27.9 million in revenue, down 3.5% sequentially.
Looking at the longer-term picture, OM's 5-year compound annual growth rate (CAGR) stands at +19.1%, indicating consistent double-digit revenue growth. The company achieved its highest annual revenue of $130.4 million in 2023.
Revenue diversification analysis shows OM's business is primarily driven by Product (42%), Consumables Product (26%), and Service And Other Revenue (17%).
When compared to Healthcare sector peers including DVA (+6.7% YoY), FMS (-0.7% YoY), and HCAT (+1.5% YoY), OM has underperformed the peer group in terms of revenue growth. Compare OM vs DVA →
OM Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| OMCurrent | $118M | -6.3% | +19.1% | -55.8% | |
 DVA | $13.6B | +6.7% | +3.4% | 14.7% | |
 FMS | $19.6B | -0.7% | +1.9% | 9.3% | |
 HCAT | $311M | +1.5% | +10.5% | -51.7% | |
 BDX | $21.8B | +2.4% | +6.3% | 11.8% | |
 BAX | $11.2B | +5.1% | -0.7% | -2.7% |
OM Historical Revenue Data (2018–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $119.5M | +5.1% | $46.8M | 39.1% | $-66,714,000 | -55.8% |
| 2024 | $113.7M | -12.8% | $38.6M | 33.9% | $-113,375,000 | -99.7% |
| 2023 | $130.4M | +13.0% | $29.0M | 22.2% | $-169,770,000 | -130.2% |
| 2022 | $115.4M | +12.4% | $17.8M | 15.5% | $-161,019,000 | -139.6% |
| 2021 | $102.6M | +105.5% | $7.6M | 7.4% | $-130,519,000 | -127.2% |
| 2020 | $49.9M | +231.2% | $-13,037,000 | -26.1% | $-117,467,000 | -235.2% |
| 2019 | $15.1M | +651.3% | $-17,802,000 | -118.1% | $-70,307,000 | -466.3% |
| 2018 | $2.0M | - | $-6,115,000 | -304.7% | $-46,563,000 | -2320.0% |
See OM's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs OM Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare OM vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonOM — Frequently Asked Questions
Quick answers to the most common questions about buying OM stock.
Is OM's revenue growth accelerating or slowing?
OM revenue declined -6.3% year-over-year, contrasting with the 5-year CAGR of +19.1%. TTM revenue fell to $118M. This reverses the prior growth trend.
What is OM's long-term revenue growth rate?
Outset Medical, Inc.'s 5-year revenue CAGR of +19.1% reflects the variable expansion pattern. Current YoY growth of -6.3% is below this long-term average.
How is OM's revenue distributed by segment?
OM reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2018-2025 are available for download. Segment mix reveals concentration and diversification trends.